GMGrace Oluwatoyin Mensah-Agyei

Grace Oluwatoyin Mensah-Agyei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Grace Oluwatoyin Mensah-Agyei has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Imipenem Resistance: A Clarion Call to Antibiotic Stewardship

    by Grace Oluwatoyin Mensah-Agyei, Samuel Adebayo Adeniyi, Emmanuel Oladipo Babafemi, Olufemi Ezekiel Adeleke

    Background Imipenem, a carbapenem antibiotic with a broader antimicrobial spectrum and greater potency than other beta-lactam antibiotics, has been considered a last-resort antibiotic for severe Gram-negative infections. However, escalating resistance now threatens its clinical utility worldwide. This review synthesizes current knowledge on the epidemiology, molecular mechanisms, and therapeutic challenges associated with imipenem resistance in clinically significant pathogens such as Klebsiella pneumoniae , Escherichia coli, Pseudomonas aeruginosa , and Acinetobacter baumannii . Resistance arises through diverse pathways—including carbapenemase production, porin loss, efflux pump overexpression, and synergistic mutations—that collectively diminish drug efficacy and complicate treatment. Methods A systematic literature search was conducted across four major electronic databases — PubMed, Scopus, ScienceDirect, and Google Scholar — to identify relevant publications on imipenem resistance, carbapenem resistance mechanisms, clinical outcomes, and antibiotic stewardship interventions. Sixty-six publications met the inclusion criteria. Results Therapeutic options remain limited, often relying on toxic or suboptimal agents such as colistin, while emerging alternatives—including β-lactam/β-lactamase inhibitor combinations, cefiderocol, antimicrobial peptides, bacteriophages, and immunomodulatory approaches—show promise but are not yet universally accessible. Effective management therefore requires integration of precision diagnostics, antimicrobial stewardship, and infection prevention strategies to optimize therapy and contain transmission. Conclusion Coordinated action across bedside practice, hospital policy, and global health governance is essential to preserve existing therapies and accelerate the development of sustainable alternatives. Without decisive intervention, the continued rise of imipenem resistance may herald a post-antibiotic era in which even routine infections become untreatable.

  • Open Access

    Prevalence of Chikungunya Virus IgG and IgM Antibodies among Febrile Patients Presumptively Diagnosed with Malaria in Ogun State, Nigeria

    by Favour A Idowu, Seyi S Enitan, Michael U Iduh, Stephen O Makanjuola, Richard Y Akele, Okeoghene M Edafetanure-Ibeh, Grace O Mensah-Agyei, Grace E Itodo, Esther O Adetiloro, Effiong J Effiong

    Background and study aim: In Nigeria, there is paucity of information on the epidemiology of infections due to Chikungunya virus (CHIKV) especially among patients with febrile illness. Cases of febrile illness are usually associated with malaria and typhoid fever without considering the possibility of viral aetiology. The aim of the study was to determine the prevalence and associated risk factors of CHIKV infections among febrile illness presumptively diagnosed of malaria in Ogun State, Nigeria. Patients and Methods: A total of 165 patients (94 females and 71 males) were recruited for the study. The presence of malarial parasite was determined by microscopic examination of blood films. Sera were tested for presence of CHIKV immunoglobin (Ig) IgM and IgG antibodies using CHIKV rapid diagnostic test kit. Results: Out of the 165 patients screened, 102 (61.8%) were positive for malarial parasite, 18 (10.9%), 5 (3.0%) and 4 (2.4%) were positive for the presence of CHIKV IgM Ab only, CHIKV IgG Ab only, and both, respectively. A statistically significant association was observed between CHIKV IgM antibody positivity and malaria. Participants who tested positive for CHIKV IgG antibody only were all negative for malaria. Meanwhile, participants positive for both CHIKV IgM and IgG antibodies did not test positive for malaria. Lack of knowledge of CHIKV, presence of mosquitos in the environment, presence of stagnant water sources around, lack of routine medical check-ups and self-medication practices are some of the risk factors identified in this study. Conclusion: The findings underscore the importance of considering CHIKV infection alongside malaria in febrile patients, particularly in malaria-endemic regions.


  • Open Access

    Bacterial diversity, antibiogram and nutritional assessment of cowhide (Ponmo) in Ilishan-Remo central market, Nigeria

    by Mensah-Agyei Grace Oluwatoyin, Adaramola Feyisara Banji, Akpan Nevillah Nice, Egbeobawaye Jennifer Orobosa, Akeredolu Abosede Abolanle, Enitan Seyi Samson, Ajibade Oluwatosin

  • Open Access

    Phytochemical Screening, Proximate Analysis and Microbiological Quality of Bio-Clean II Herbal Remedy

    by Seyi Samson Enitan, Isaiah Nnanna Ibeh, Christy Chinwe Isitua, Michael Olugbamila Dada, Grace Oluwatoyin Mensah-Agyei, Grace Eleojo Itodo, Richard Yomi Akele, Peace Ojonugwa Idris